In certain cancers, HER2 becomes overexpressed or uncontrolled, driving tumors to develop quickly. As our understanding of HER2 and its role deepens, its relevance across endometrial, ovarian and other gynecologic tumors has become…
A career of building hope for people with cancer began with a single childhood moment for our Vice President, Global Team Leader, Oncology Research & Development, Dalila Sellami, MD.
As a teenager volunteering at a hospital, Simon King, Chief People Officer at Daiichi Sankyo, Inc., learned the difference between listening with his ears and listening with his heart.
Daiichi Sankyo supports “No One Missed” campaign to build awareness, empower patients and break down barriers to this essential step in cancer care.
As a champion of continuous learning, John Ruggiero, Ph.D., leverages the power of diverse voices to create better tomorrows for patients.
In Japanese, the word for home is uchi, うち. For Gerold Meinhardt, M.D., Ph.D., a German native living in the U.S., his true uchi is Japan.
After suffering a traumatic brain injury in a motor vehicle accident more than 15 years ago, Barbara Tantillo was challenged to redefine what success looks like as a person living with a non-apparent disability.